When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
By Anuja Vaidya
November 06, 2023 – A bipartisan group of four senators reintroduced legislation that would eliminate barriers to the virtual prescription of medication for opioid use disorder (OUD).
Called the Telehealth Response for E-prescribing Addiction…
Continue Reading
The DEA has extended remote prescribing of controlled substances until the end of 2024, granting a second extension to consider new regulations. This move eliminates the proposed rule requiring in-person visits for controlled medication…
Continue Reading
This is a developing story with updates expected.U.S. Senators Mark Warner (D-Va.), John Thune (R-S.D.) and four of their colleagues expressed support for the Drug Enforcement Administration’s new engagement on a potential special registration…
Continue Reading
As the Drug Enforcement Administration (DEA) holds listening sessions this week for its proposed rule that rolls back Covid-19 flexibilities for the virtual prescribing of controlled substances, four mental health companies issued a letter…
Continue Reading
By Mark Melchionna
June 29, 2023 – Amid the ongoing concerns surrounding virtual prescribing allowances for attention-deficit hyperactivity disorder (ADHD) medications, a new study found that health systems provide prescriptions for this condition and anxiety at…
Continue Reading
The U.S. Drug Enforcement Administration’s stance on prescribing via telehealth has been evolving, with hints toward an appetite for lasting flexibilities. This, among other policy shifts, has a direct impact on healthcare provider organizations…
Continue Reading
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading
Top News
The Drug Enforcement Administration, reacting to the record 38,000 comments it received about its intention to reinstate pre-COVID telehealth prescribing limitations for controlled drugs with the end of the public health emergency, will…
Continue Reading
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…
